FDA Recall Terminated Historical recordClass III
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56
- Reason
- Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.
- Published
- July 26, 2017
- Distribution
- Nationwide
